Merck & Co/MSD’s three-drug antibiotic Recarbrio ... and Pfizer’s Amsparity – a biosimilar of AbbVie’s immunology blockbuster Humira (adalimumab).

Merck & Co’s immuno-oncology drug Keytruda ... to overtake AbbVie and Eisai’s anti-inflammatory drug Humira (adalimumab), which is currently the world’s top-selling drug,” says Keshalini ...

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

After hours: 7:59:39 p.m. EST Loading Chart for MRK ...

Pre-market: 5:02:58 am GMT-5 ...

Objective Neutralising pro-inflammatory interleukin-6 (IL-6) may effectively treat Crohn’s disease (CD). Effects of PF-04236921, an anti-IL-6 antibody, in adults with CD are reported. Results 247 ...